返回 Agenda
LS16 Current Status and Future of Digital Therapeutics (DTx): How DTx Are Developed and Penetrate Medical Care
Session Chair(s)
Takashi Sawada
Sr. Scientist, Oncology Clinical Developoment, MSD K.K., Japan
Speaker(s)
Yuta Watanabe
Senior Vice President, Head of Rx+ Business Accelerator, Astellas Pharma Inc., Japan
Yusuke Yajima
COO, SUSMED, Inc , Japan
Ayako Tomiyasu
Office of Medical Devices 1, Pharmaceuticals and Medical Devices Agency, Japan
Takanori Sando
Planning and promotion, Cmic.,co.,Ltd, Japan